美国 · 财经报刊 · Investor's Business Daily
Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Shoots Higher
Rapport Therapeutics stock shot higher Tuesday on promising, but mixed, test results for its bipolar treatment. The post Can This Small Biotech Enter A $4.3 Billion AbbVie Market?…
在 Investor's Business Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)
